These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1378912)

  • 21. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.
    Devine DV; Siegel RS; Rosse WF
    J Clin Invest; 1987 Jan; 79(1):131-7. PubMed ID: 2432087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of phosphatidylinositol-linked membrane proteins on erythrocytes of different subpopulations in paroxysmal nocturnal hemoglobinuria.
    Cui Y; Zhang ZN; Liu EK; Pan HZ
    Chin Med J (Engl); 1993 May; 106(5):323-30. PubMed ID: 7691484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
    Nilsson B; Hagström U; Englund A; Säfwenberg J
    Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
    Fujioka S; Yamada T
    Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase.
    Burroughs SF; Devine DV; Browne G; Kaplan ME
    Blood; 1988 Apr; 71(4):1086-9. PubMed ID: 2451546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced complement-susceptibility and dysfunction of lymphocytes in paroxysmal nocturnal haemoglobinuria (PNH).
    Tomiyama J; Ninomiya H; Abe T
    Br J Haematol; 1990 Dec; 76(4):540-4. PubMed ID: 1702310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.
    Davitz MA; Low MG; Nussenzweig V
    J Exp Med; 1986 May; 163(5):1150-61. PubMed ID: 2422313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
    Zalman LS; Wood LM; Frank MM; Müller-Eberhard HJ
    J Exp Med; 1987 Feb; 165(2):572-7. PubMed ID: 2434597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Medof ME; Silber R; Nussenzweig V
    J Exp Med; 1985 Jul; 162(1):75-92. PubMed ID: 2409211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor).
    Merry AH; Rawlinson VI; Uchikawa M; Daha MR; Sim RB
    Br J Haematol; 1989 Oct; 73(2):248-53. PubMed ID: 2479410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional differences between decay-accelerating factor and red cell acetylcholinesterase.
    Sugarman J; Devine DV; Rosse WF
    Blood; 1986 Sep; 68(3):680-4. PubMed ID: 2427138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
    Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
    Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Fredrick LR; Bernshaw NJ; Wilcox LA; Parker CJ
    J Clin Invest; 1989 Jul; 84(1):7-17. PubMed ID: 2738160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement.
    Ezzell JL; Wilcox LA; Bernshaw NJ; Parker CJ
    Blood; 1991 Jun; 77(12):2764-73. PubMed ID: 1710519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Okuda K; Kanamaru A; Ueda E; Kitani T; Okada N; Okada H; Kakishita E; Nagai K
    Exp Hematol; 1990 Nov; 18(10):1132-6. PubMed ID: 1698649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Nakakuma H; Kawaguchi T; Horikawa K; Hidaka M; Yonemura Y; Kawakita M; Kagimoto T; Iwamori M; Nagai Y; Takatsuki K
    J Clin Invest; 1990 May; 85(5):1456-61. PubMed ID: 2185273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paroxysmal nocturnal hemoglobinuria--diagnosis with the help of flow cytometry].
    Vetlesen A; Kjeldsen-Kragh J; Tjonnfjord GE
    Tidsskr Nor Laegeforen; 1999 Oct; 119(26):3909-13. PubMed ID: 10592751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of PI-bound proteins on blood cells from PNH patients by quantitative flow cytometry.
    Plesner T; Hansen NE; Carlsen K
    Br J Haematol; 1990 Aug; 75(4):585-90. PubMed ID: 1698448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.